65576-45-6

We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Asenapine (CAS No.: 65576-45-6) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Asenapine (CAS No.: 65576-45-6) and other compounds. We can provide high-quality compounds and good service for you.

Send Inquiry

Product Description

Name	Asenapine
Synonyms	L-Ascorbic Acid 6-Palmitate;scorbicpalmitate;Vitamin C Palmitate;<36Cl>-trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz<2,3:6,7>oxepino<4,5-c>pyrrole;6-palmitoylascorbic acid;trans-5-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz<2,3:6,7>oxepino<4,5-c>pyrrolidine
Molecular Formula	C₁₇H₁₆ClNO
Molecular Weight	401.84000
CAS Number	65576-45-6
purity	≥98%

application：Asenapine (USAN, rINNM and BANM; trade names Saphris (AU, US, RU), Sycrest (EU, UK)) (CAS No.: 65576-45-6) is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merger with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel. Preliminary data indicate that it has minimal anticholinergic and cardiovascular side effects, as well as minimal weight gain. Over 3000 patients have participated in clinical trials of asenapine, and the FDA approved the manufacturer's NDA in August 2009.
It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.

Hot Tags: